Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Adventrx Requests Meeting with FDA to Discuss ANX-514 Study
Adventrx Requests Meeting with FDA to Discuss ANX-514 Study
Adventrx Requests Meeting with FDA to Discuss ANX-514 Study
Submitted by
admin
on December 19, 2010 - 11:34am
Source:
PR-USA
News Tags:
Taxotere
cancer
ANX-514
Adventrx
Headline:
Adventrx Requests Meeting with FDA to Discuss ANX-514 Study
Do Not Allow Advertisers to Use My Personal information
